Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?

Demonstration of cell‐mediated immunity to human neoplasms of various histological types

1971 • 673 citations

Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the Disease

1969 • 396 citations

Demonstration of antibodies against human malignant melanoma by immunofluorescence.

1968 • 390 citations

Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.

1995 • 338 citations

Surgical Resection for Melanoma Metastatic to the Gastrointestinal Tract

1996 • 265 citations

Analysis of 945 cases of pulmonary metastatic melanoma

1992 • 231 citations

Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine.

1998 • 162 citations

Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax

1995 • 157 citations

Surgical treatment of distant metastatic melanoma indications and results

1985 • 133 citations

Metastasectomy in malignant melanoma.

1994 • 123 citations

The natural history of resectable metastatic melanoma (Stage IVA Melanoma)

1982 • 117 citations

Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.

1982 • 112 citations

Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma

1999 • 93 citations

Inhibition of interleukin 2 production by factors released from tumor cells.

1983 • 87 citations

Role of surgical intervention in the management of intestinal metastases from malignant melanoma

1991 • 83 citations

Decreased interleukin−2 production in patients with gastrointestinal cancer

1986 • 83 citations

Clinical and immunological significance of human melanoma cytotoxic antibody.

1975 • 76 citations

The role of surgery in the treatment of nonregionally recurrent melanoma.

1993 • 75 citations

Depression of lymphocyte responses after surgical trauma.

1973 • 73 citations

Induction of antibodies to a tumor-associated antigen by immunization with a whole melanoma cell vaccine

1989 • 44 citations

Thoracotomy for metastatic malignant melanoma of the lung.

1990 • 42 citations

Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): Correlation with survival

1998 • 37 citations

Humoral cytotoxicity in melanoma patients and its correlation with the extent and course of the disease

1975 • 33 citations

Monoclonal antibody‐based ELISA to detect glycoprotein tumor‐associated‐antigen‐specific immune complexes in cancer patients

1992 • 29 citations

Failure of Cell-Mediated Effector Mechanisms in Lung Cancer<xref ref-type="fn" rid="FN2">2</xref>

1984 • 23 citations

Lymphocyte response to phytohaemagglutinin following cholecystectomy.

1969 • 22 citations

Monocyte disorders associated with T cell defects in patients with solid tumors.

1992 • 15 citations